Latest Blog Posts
FDA May Add New Warnings to Breast Implant Products
| October 29th, 2019
The U.S. Food and Drug Administration (FDA) recently announced that it is considering new labeling recommendations for breast implants that will help patients better understand the risks of the product and the surgical procedures involved. In a press release, the agency indicated that it has heard from many women who said they weren’t fully informed
Read MoreAvoid These 3 Common Defective Medical Device Mistakes
| July 30th, 2019
Medical devices are designed to alleviate symptoms, reduce pain, and improve quality of life. But like all manufactured products, medical devices are subject to variances in quality. In addition, some medical devices may be inherently flawed due to poor designs or the use of cut-rate components that break down inside patients’ bodies. If you or
Read MoreFDA Announces Class I Recall of Defective Surgical Stapler and Staples
| July 9th, 2019
In April 2019, we discussed the U.S. Food and Drug Administration’s (FDA) findings of serious injuries and even deaths related to malfunctioning surgical staplers and misapplied surgical staples. In May 2019, the FDA announced that Ethicon was recalling its circular staplers due to their tendency to misfire and to fail to completely form staples, both
Read MoreFentanyl Patches Recalled Due to Potentially Life-Threatening Labeling Error
| June 11th, 2019
At Ferrer, Poirot & Wansbrough, we’ve helped many people who were harmed by fentanyl pain patches. These transdermal patches are designed to relieve chronic pain, but some manufacturing defects have resulted in large quantities of the drug being released into wearers’ bloodstreams. Because fentanyl is 80 times more potent than morphine, even tiny overdoses of
Read More